Oct 8 (Reuters) - Daiichi Sankyo Co Ltd 4568.T :
- ENTERS DISTRIBUTION AND LICENSE AGREEMENT WITH DAIICHI SANKYO FOR PENTHROX IN CHINA, THAILAND & VIETNAM
- DAIICHI SANKYO WILL PAY CO UP TO US$32.5 MILLION
- MVP WILL FUND APPROVAL PROCESS UP TO US$10 MILLION & WILL OWN INTELLECTUAL PROPERTY GENERATED FROM PROGRAM
- CO & DAIICHI SANKYO TO ENTER AGREEMENT WITH EPS INTERNATIONAL HOLDINGS TO GET PENTHROX APPROVED FOR SALE IN CHINA
News: MVP Medical Developments International Enters Distribution & License Deal With Daiichi Sankyo
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.04M | |||
| Open | High | Low | Value | Volume |
| 68.0¢ | 69.0¢ | 66.5¢ | $138.8K | 203.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14989 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2025 (20 minute delay) ? |
| MVP (ASX) Chart |